Clinical Trial Update: Examination of a Soy-Based Supplement for Major Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a soy-based supplement for major depressive disorder has completed; no results are provided in the available excerpt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Soy-based supplement

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Depression | Phase 2 | Status: COMPLETED